BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6290534)

  • 1. Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes.
    Boxer LA; Haak RA; Yang HH; Wolach JB; Whitcomb JA; Butterick CJ; Baehner RL
    J Clin Invest; 1982 Nov; 70(5):1049-57. PubMed ID: 6290534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness.
    Oseas R; Yang HH; Baehner RL; Boxer LA
    Blood; 1981 May; 57(5):939-45. PubMed ID: 7214024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor.
    Ingraham LM; Coates TD; Allen JM; Higgins CP; Baehner RL; Boxer LA
    Blood; 1982 Jun; 59(6):1259-66. PubMed ID: 6282362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cell surface contact in the kinetics of superoxide production by granulocytes.
    Dahinden CA; Fehr J; Hugli TE
    J Clin Invest; 1983 Jul; 72(1):113-21. PubMed ID: 6308042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of heparin and chemotactic factor on polymorphonuclear leukocyte aggregation and degranulation.
    Cairo MS; Allen J; Higgins C; Baehner RL; Boxer LA
    Am J Pathol; 1983 Oct; 113(1):67-74. PubMed ID: 6624878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC; Hughes BJ; Smith CW
    J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation.
    Oseas RS; Boxer LA; Butterick C; Baehner RL
    J Lab Clin Med; 1980 Aug; 96(2):213-21. PubMed ID: 7400660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte activation by endotoxin. II. Role of granulocyte adherence, aggregation, and effect of cytochalasin B, and comparison with formylated chemotactic peptide-induced stimulation.
    Dahinden C; Fehr J
    J Immunol; 1983 Feb; 130(2):863-8. PubMed ID: 6294179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of polymorphonuclear leukocyte function by cetiedil.
    Wolach JB; Coates TD; Tzeng DY; Baehner RL; Boxer LA
    Blood; 1983 Aug; 62(2):274-9. PubMed ID: 6307427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sequential release of granule constitutents from human neutrophils.
    Bentwood BJ; Henson PM
    J Immunol; 1980 Feb; 124(2):855-62. PubMed ID: 6153206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP; Seligmann BE; Gallin JI
    J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin binds to neutrophilic membrane DNA.
    Bennett RM; Merritt MM; Gabor G
    Br J Haematol; 1986 May; 63(1):105-17. PubMed ID: 3707857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lactoferrin reflects granulocyte activation in vivo.
    Lash JA; Coates TD; Lafuze J; Baehner RL; Boxer LA
    Blood; 1983 May; 61(5):885-8. PubMed ID: 6831049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological changes in human polymorphonuclear leukocytes induced by C3a in the presence and absence of cytochalasin B.
    Showell HJ; Glovsky MM; Ward PA
    Int Arch Allergy Appl Immunol; 1982; 69(1):62-7. PubMed ID: 6980842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subpopulation of human polymorphonuclear neutrophils contains an active form of lactoferrin capable of binding to human monocytes and inhibiting production of granulocyte-macrophage colony stimulatory activities.
    Broxmeyer HE; Ralph P; Bognacki J; Kincade PW; Desousa M
    J Immunol; 1980 Aug; 125(2):903-9. PubMed ID: 7391584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin binds to cell membrane DNA. Association of surface DNA with an enriched population of B cells and monocytes.
    Bennett RM; Davis J; Campbell S; Portnoff S
    J Clin Invest; 1983 Mar; 71(3):611-8. PubMed ID: 6600747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+ T cells and its modulation on Th1/Th2 cytokine production.
    Li KJ; Lu MC; Hsieh SC; Wu CH; Yu HS; Tsai CY; Yu CL
    J Leukoc Biol; 2006 Aug; 80(2):350-8. PubMed ID: 16769765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of the antiinflammatory agents dexamethasone and Auranofin in human polymorphonuclear leukocytes.
    Coates TD; Wolach B; Tzeng DY; Higgins C; Baehner RL; Boxer LA
    Blood; 1983 Nov; 62(5):1070-7. PubMed ID: 6313097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Zinkl JG; Brown PD
    Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.